SJS Investment Consulting’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-151
Closed -$15.3K 2507
2025
Q4
$15.3K Buy
151
+148
+4,933% +$11.9K ﹤0.01% 693
2025
Q3
$165 Sell
3
-5
-63% -$250 ﹤0.01% 1506
2025
Q2
$426 Buy
8
+2
+33% +$102 ﹤0.01% 1165
2025
Q1
$260 Sell
6
-2
-25% -$101 ﹤0.01% 1410
2024
Q4
$450 Sell
8
-2
-20% -$124 ﹤0.01% 1276
2024
Q3
$682 Sell
10
-1
-9% -$56 ﹤0.01% 1216
2024
Q2
$465 Sell
11
-2
-15% -$110 ﹤0.01% 1315
2024
Q1
$898 Hold
13
﹤0.01% 1080
2023
Q4
$962 Sell
13
-4
-24% -$262 ﹤0.01% 974
2023
Q3
$1.16K Sell
17
-1
-6% -$85 ﹤0.01% 865
2023
Q2
$1.69K Buy
18
+6
+50% +$468 ﹤0.01% 669
2023
Q1
$814 Buy
12
+2
+20% +$129 ﹤0.01% 976
2022
Q4
$495 Buy
10
+6
+150% +$245 ﹤0.01% 1222
2022
Q3
$0 Buy
+4
New +$165 ﹤0.01% 1187
2022
Q1
$9K Buy
129
+1
+0.8% +$73 ﹤0.01% 397
2021
Q4
$10K Buy
+128
New +$11.3K ﹤0.01% 371

Other funds holding EXAS

SJS Investment Consulting's EXAS Position: Q1 2026 in Review

SJS Investment Consulting sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 151 shares — an estimated $15.3K sold.

SJS Investment Consulting first reported a position in EXAS in Q4 2021 and held it in 16 quarters. The position peaked at $15.3K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • SJS Investment Consulting reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • SJS Investment Consulting sold 151 Exact Sciences shares in Q1 2026, an estimated $15.3K.
  • SJS Investment Consulting first reported a position in Exact Sciences in Q4 2021 and held it in 16 quarters.
  • SJS Investment Consulting's Exact Sciences position peaked at $15.3K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on SJS Investment Consulting's 13F filing for Q1 2026, filed 23 Apr 2026.